Endonovo Therapeutics Market Cap

Endonovo Therapeutics has a market cap or net worth of $219.58 thousand as of April 25, 2025. Its market cap has decreased by -88.52% in one year.

Market Cap

219.58K

Enterprise Value

7.28M

Revenue

255.72K

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.00

Market Cap Chart

Since February 20, 2013, Endonovo Therapeutics's market cap has increased from 78.90K to 219.58K, an increase of 178.31%. That is a compound annual growth rate of 8.76%.

Market Cap History

Date	Market Cap	% Change
Apr 25, 2025	219.58K	0.94%
Dec 31, 2024	217.55K	-92.16%
Dec 29, 2023	2.77M	-20.72%
Dec 30, 2022	3.50M	211.37%
Dec 31, 2021	1.12M	127.79%
Dec 31, 2020	493.17K	-74.11%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo Inc.	1.63B
Nika Pharmaceuticals	1.02B
Veradigm	746.57M
Glass House Brands	500.84M
Elite Pharmaceuticals	450.22M
Northwest Biotherapeutics	443.51M
CytoDyn	284.32M
BioStem Technologies	245.41M

Market Cap Rankings